New Fellowship of the Association of Cancer Physicians

Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study

Jackson A. et al, (2026), Lancet Regional Health Europe, 66

Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.

Puhr HC. et al, (2026), Eur J Cancer, 241

Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response

Peralta Alvarez MP. et al, (2026), Vaccines, 14, 509 - 509

Nucleophagy removes cytotoxic trapped PARP1.

Hoslett G. et al, (2026), Nat Cell Biol

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).

Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12

MAFF regulates ferroptotic sensitivity through iron homeostasis and fatty acid synthesis.

Vilaplana Lopera N. et al, (2026), Cell Death Dis

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

Matsubara Y. et al, (2026), ESMO Open, 11

Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

Schmid P. et al, (2026), Clin Cancer Res

Improved attenuation correction registration for FDG PET/CT images using data-driven gating (DDG)-based motion match.

Wilson Z. et al, (2026), EJNMMI Phys

Radiation dose-dependent skin toxicity and therapeutic advantage of FLASH radiotherapy via immune modulation.

Paillas S. et al, (2026), Int J Radiat Oncol Biol Phys

PHGDH loss promotes hypoxia tolerance through glycolytic reprogramming and enhanced HIF-1 activity

Petrosyan E. et al, (2026), Cell Death Discovery

Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.

Castro-Dopico T. et al, (2026), Nat Cancer

Exosomal survivin as a liquid biopsy biomarker in cancer.

Wijaya W. et al, (2026), J Immunol Methods, 548

Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors.

Seguchi K. et al, (2026), Clin Cancer Res

Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizons.

Zhu H. et al, (2026), Nat Rev Clin Oncol

Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic Plasmodium falciparum sporozoite challenge in mice

Turan G. et al, (2026), Frontiers in Immunology, 17

Germline polygenic score for prostate cancer aggressiveness.

Xu GJ. et al, (2026)

Negative-pressure wound therapy in thoracic and abdominal surgery: meta-analysis of randomized trials.

Lakha AS. et al, (2026), BJS Open, 10

Catalog of gut microbiota alterations associated with anticancer therapies across multiple cancer types

Kurihara K. et al, (2026)

Germline haploinsufficiency of MUTYH causes mutational signature SBS18 in multiple tumour types and specifically raises colorectal cancer risk.

Sherwood K. et al, (2026), NPJ Precis Oncol

Search results

Showing results for